1. Collections at PSGRKCW
  2. C-PubMed
  3. 2005-2024
  4. a) Abstract
Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/5165
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJincy, C S-
dc.contributor.authorMeena, P-
dc.date.accessioned2024-09-10T08:21:18Z-
dc.date.available2024-09-10T08:21:18Z-
dc.date.issued2022-03-
dc.identifier.urihttps://doi.org/10.1016/j.jtemb.2021.126916-
dc.description.abstractThis contribution of work describes a new strategy for manufacturing cobalt oxide nanoparticles and the results assured that, its efficiency was increased by adding Fe ions. The anticancer drugs usually have a limited medical value owing to their nonspecific cytotoxicity. It has been proven that by using the nanosystems to deliver tablets to tumour cells reduces the toxic quality. Because of these qualities, nanoparticles can be used as a stronger rival for potent cancer treatment.en_US
dc.language.isoen_USen_US
dc.publisherElsevier GmbHen_US
dc.titleEVALUATION OF CYTOTOXIC ACTIVITY OF FE DOPED COBALT OXIDE NANOPARTICLESen_US
dc.typeArticleen_US
Appears in Collections:a) Abstract

Files in This Item:
File Description SizeFormat 
EVALUATION OF CYTOTOXIC ACTIVITY OF FE DOPED COBALT OXIDE NANOPARTICLES.docx531.53 kBMicrosoft Word XMLView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.